Evidence map›Paper›PMID 40208384›Full record

ReviewIndian journal of pediatrics2025

Adenoviral Infections in Immunocompetent Children.

Valsan Philip Verghese

Abstract readReview
PubMed Publisher
In one paragraph

Review in Indian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Valsan Philip VergheseDepartment of Pediatrics, Christian Medical College, Vellore, Tamil Nadu, 632004, India. valsan@cmcvellore.ac.in.ORCID 0000-0001-6507-7795

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenoviruses are a common cause of upper and lower respiratory infections, gastroenteritis and conjunctivitis in children. Although most adenoviral infections are self-limited, those caused by certain serotypes during outbreaks have led to severe pneumonias and poorer outcomes, with sequelae of bronchiectasis and bronchiolitis obliterans in survivors. Rarer manifestations such as central nervous system and urinary infections can also lead to severe disease. Adenoviruses can be shed for prolonged periods after infection and can also lead to persistent subclinical infection with the potential for reactivation during periods of immunosuppression. Diagnosis with polymerase chain reaction (PCR) testing is highly sensitive and specific but attributing causation in PCR positive children will depend on the presence of symptomatic disease. Treatment is predominantly supportive with maintenance of hydration in gastroenteritis and respiratory support in severe pneumonia. Although antiviral drugs are used in immunocompromised and transplanted children, they are not recommended for use in immune competent children especially in the absence of efficacy data. As adenoviruses are spread by droplet transmission and can survive on surfaces for weeks, infection control measures include isolation of patients, proper disinfection and use of personal protective equipment. Because adenoviruses are known to undergo spontaneous mutations and recombinant events leading to novel viruses and have caused fatal co-infections in the past, molecular surveillance of adenovirus is needed to monitor circulating serotypes, to recognise new disease emergence and to prevent epidemic spread.

Indexed as

Adenoviridae InfectionsAdenovirus Infections, HumanImmunocompetenceChildHumansAdenoviral conjunctivitisAdenoviral gastroenteritisAdenovirus infectionEpidemic serotypesMolecular adenoviral surveillanceSevere pneumonia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.